Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Apilimod mesylate

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AI Therapeutics Announces Start of Ph II Trial of LAM-002A (apilimod dimesylate)
    AI Therapeutics Announces Start of Ph II Trial of LAM-002A (apilimod dimesylate)

    27 Jul 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200727005096/en

    BUSINESSWIRE
    27 Jul 2020
    Share Share
    AI Therapeutics Announces Start of Phase II Trial of LAM-002A
    AI Therapeutics Announces Start of Phase II Trial of LAM-002A

    27 Jul 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200727005096/en/AI-Therapeutics-Announces-Start-Phase-II-Trial

    BUSINESSWIRE
    27 Jul 2020
    Share Share